Latest revenue
$423.5K
as of 2026-03-31
Latest net income
$-1.6M
as of 2026-03-31
Net margin
-382.9%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $6.0M
- Enterprise value
- $6.0M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $6.50
- 52-wk low
- $0.02
- Beta
- —
- Shares out
- 2.9M
5-year trend
What this company does
Item 1. Business Overview HealthLynked Corp. (the “Company,” “we,” “our,”) is a healthcare technology company incorporated in the State of Nevada on August 6, 2014. We operate across three primary divisions – Digital Healthcare, Health Services, and Medical Distribution – each dedicated to leveraging innovative solutions that enhance patient care, reduce costs, and generate long-term value for stockholders. Our key objectives are to: 1. Improve patient care management; 2. Enhance the operational efficiency of medical practices; and 3. Utilize healthcare data to gain unique insights into diseases, leading to better health outcomes Digital Healthcare Division Within our Digital Healthcare…
AI summary unavailable — showing raw filing excerpt
Generated from HLYK's filing dated 2026-03-31
Key risks
Item 1A. Risk Factors Our business, financial condition, results of operations and cash flows may be affected by a number of factors including, but not limited to those set forth below. This discussion should be considered in conjunction with the discussion under the caption “Forward-Looking Statements” preceding Part I, the information set forth under Item 1, “Business” and with the discussion of the business included in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These risks comprise the material risks of which we are aware. If any of the events or developments described below or elsewhere in this Annual Report on Form 10-K, or…
AI summary unavailable — showing raw filing excerpt
Generated from HLYK's filing dated 2026-03-31
Profitability
Operating margin
-155.5%
114.3%Net margin
-158.8%
22.1%Return on equity
56.9%
70.9%Return on assets
-192.7%
30.1%Leverage
Debt / equity
-1.30×
24.3%Long-term debt / equity
0.46×
21.4%Debt / assets
438.5%
82.1%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $423.5K | -45.3% | $-1.6M | -54.3% | -382.9% |
Q4 2025 2025-12-31 | $310.2K | -49.9% | $-676.5K | +45.0% | -218.1% |
Q3 2025 2025-09-30 | $388.5K | -34.2% | $-851.8K | +56.8% | -219.2% |
Q2 2025 2025-06-30 | $592.4K | -25.5% | $-701.0K | +54.5% | -118.3% |
Q1 2025 2025-03-31 | $774.2K | -22.9% | $-1.1M | +24.3% | -135.7% |
Q4 2024 2024-12-31 | $618.9K | — | $-1.2M | — | -198.8% |
Q3 2024 2024-09-30 | $590.1K | -55.7% | $-2.0M | -1028.0% | -334.4% |
Q2 2024 2024-06-30 | $795.1K | -51.2% | $-1.5M | -443.5% | -193.7% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Offices & Clinics of Doctors of Medicine · SIC 8011
Your notes
Keep private notes on HLYK — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
No insider transactions on file for HLYK in the last 12 months.
Source: SEC Form 4 filings. Backfill runs nightly.
Who owns HLYK
No institutional holdings on file for HLYK yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once HLYK's latest filing finishes processing.